Medical artificial intelligence solution development company WeRubi announced on the 28th that it will participate as a medical field demonstration company in the '2025 AI Semiconductor Farm Construction and Demonstration' project hosted by the National IT Industry Promotion Agency.
This project aims to strengthen the competitiveness of the domestic AI semiconductor ecosystem by building a high-performance, low-power computing infrastructure based on domestic AI semiconductors in a cloud environment and verifying various AI services. It is structured so that demand companies, fabless companies, and cloud infrastructure companies will participate by forming a consortium, and the possibility of commercializing the technology and marketability will be reviewed through verification.
WeRubi will be in charge of the medical sector verification and will verify its brainwave-based depression early diagnosis solution, 'MonoCare', on a domestic AI semiconductor-based cloud infrastructure. MonoCare is an AI solution that quantifies the emotional state of patients using brainwave (EEG) data and provides medical staff with the data needed for early depression diagnosis in real time. It has improved analysis accuracy and patient convenience by applying a non-invasive measurement method and deep learning model.
In the verification process, WeRubi will apply EEG data collected at its Jeju headquarters to a cloud-based NPU architecture environment and verify items such as diagnostic accuracy, computational efficiency, and processing speed. It will also examine the possibility of using it in actual medical institutions’ treatment environments by utilizing a structure that can be linked with hospital information systems.
Through this demonstration, the company plans to expand the introduction of its solution to various medical institutions such as general hospitals, mental health hospitals, and nursing homes for the elderly, and to establish itself as an early diagnosis tool that can respond to the increasing problems of depression and cognitive decline in an aging society.
Son Deok-jin, development director of Wirubee, said, “This demonstration is an important opportunity to confirm the possibility of processing medical data based on domestic AI semiconductors,” and added, “We plan to present a new alternative to medical institutions in need of mental health management through reliable emotional analysis technology, and we will also pursue entry into overseas markets.”
You must be logged in to post a comment.